FOR IMMEDIATE RELEASE
Medidata Solutions’ Customers Honored in CIO 100 Awards
Wyeth Research and Array BioPharma Recognized for Generating Business Value and Achieving Innovation through Implementation of Medidata Rave
NEW YORK, N.Y. – June 15, 2009 – Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that customers Wyeth Research and Array BioPharma Inc. have both won CIO 100 awards for the creative and cutting-edge use of technology to generate business value in projects that leveraged Medidata Rave®, an industry-leading electronic data capture (EDC)/clinical data management (CDM) system that streamlinesthe clinical development process.
Wyeth Increases Operational Efficiencies, Further Enhances Safety and Decision Making
In 2007, Wyeth partnered with Medidata Solutions to implement Medidata's Rave EDC/CDM system and develop their Submission Data Tabulation Model (SDTM) standard-based clinical data warehouse. Rave’s ability to provide real-time access to interim clinical data, by significantly increasing the efficiency of data entry following patient visits, enabled dynamic trial execution methods and "early fail" business decisions for study projects and, most importantly, improved the data available for safety-related decisions. Additionally, Medidata Rave's Dynamic Tabulation Engine has more clearly defined SDTM mappings, improving the viability of Wyeth’s warehouse.
"Using the Medidata Rave EDC/CDM system has made a big difference in the efficiency of our business and safety decision processes in drug development," says Jeffrey Keisling, CIO and VP of Corporate Information Services at Wyeth. "These types of collaborations are important to help us find more effective methods to accelerate the development of new medicines and allocate our resources."
Array Integrates Medidata Rave with Visualization Software to Revolutionize Decision Making
In 2005, Array BioPharma initiated a project that leveraged the advanced integration capabilities of Medidata Rave and CoMotion® Trials, a cutting-edge visualization system from General Dynamics Viz initially used by the military, to create a first-of-its-kind decision support tool. This integration has allowed Array to provide their clinical scientists with real-time data that enables critical decision making across their portfolio. With Rave’s ability to quickly make data available within very short time frames of the data being entered, Array has achieved a competitive advantage over other biotech and pharmaceutical companies.
“Medidata Rave is key to making both tactical and strategic decisions that are critical to our clinical development program,” said Jim Rizzi, Sr. Director of Computational Technology, Array BioPharma. “By making operational information in Medidata Rave available in real time to the entire clinical team, we have achieved a solution that is unique in its ability to ensure the timing and success of new drug development projects.”
“We are excited that Wyeth and Array have been recognized for their business and technology innovation and we’re honored to have been able to support them in achieving their goals,” said Glen de Vries, President, Medidata Solutions. “These CIO Awards validate Medidata's commitment to providing solutions that enable our customers' strategic technology visions and help them to achieve competitive advantage.”
About the CIO 100
The recipients of this year's CIO 100 award were selected through a three-step process. First, companies filled out an online application form detailing their innovative practices in both business and IT. Next, a team of judges reviewed the applications in depth, looking for unique practices and substantial results. Finally, CIO editors reviewed the judges' recommendations and voted on the final 100. Once the top 100 honorees were selected, several honorees were chosen to receive an additional special award. Complete coverage of the 2009 CIO 100 awards will be on www.cio.com on June 1, 2009 and in the August 1st issue of CIO magazine.
About CIO Magazine
CIO produces award-winning content and community resources for information technology executives thriving and prospering in this fast-paced era of business, as well as create opportunities for information technology and consumer marketers to reach them. The CIO portfolio includes CIO.com, CIO magazine (launched in 1987), CIO Executive Programs and the CIO Executive Council. CIO properties provide business technology leaders with analysis and insight on information technology trends and a keen understanding of IT's role in achieving business goals. The U.S. edition of the magazine and website are recipients of more than 200 awards to date, including three Grand Neals from the Jesse H. Neal National Business Journalism Awards and two Magazine of the Year awards from the National Society of Business Publication Editors. CIO websites and magazines appear in more than 25 countries, including Australia, Canada, China, France and Germany. CIO, and sister brand CSO, are produced by CXO Media a subsidiary of International Data Group (IDG), the world's leading technology media, research and event company.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer™), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.
Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com